Skip to main content
Premium Trial:

Request an Annual Quote

Michelle Lyles, Greg Lucier

Premium
Michelle Lyles has been appointed vice president of marketing and sales at Febit, the German microarray company said this week. She will be based in Febit’s US office in Medford, Mass.
 
Prior to joining Febit, Lyles served as director of sales with Sigma-Aldrich's research biotechnology business unit. She also worked previously as vice president of sales and marketing with Genospectra.
 
Lyles earned her PhD in biochemistry at Baylor College of Medicine and completed post-doctoral training at Emory University. She holds a BS in biology and a BS in chemistry from the University of New Orleans.
 

 
Invitrogen has agreed to give CEO Greg Lucier an increase in his base salary to $975,000, according to a filing with the US Securities and Exchange Commission. The change was approved by the firm’s board of directors on Feb. 27 and is retroactive to Jan. 1, 2008.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.